Diagnos Laboratorium Utama Tbk. vs PP London Sumatra Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while PP London Sumatra Indonesia Tbk. trades at Rp1,325 (market cap 8.93T, 4.69M 24h volume). The key difference: PP London Sumatra Indonesia Tbk. is far larger — about 28.7× Diagnos Laboratorium Utama Tbk.'s market cap, and PP London Sumatra Indonesia Tbk. is more actively traded (4.69M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | LSIP | |
|---|---|---|
Market Cap | 310.75B | 8.93T |
Volume | 963.6K | 4.69M |
Lot | 9.64K | 46.88K |
Turnover | 217.67M | 6.22B |
Average Price | 225.89 | 1,326.55 |
Value | 217.67M | 6.22B |
Indicative Equilibrium Price | 226 | 1,325 |
Indicative Equilibrium Volume | 1K | 1.02K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Perusahaan Perkebunan London Sumatera Tbk abbreviated as Lonsum, was established in teh Republic of Indonesia based on Notarial Deed No. 93 of Raden Kadiman dated December 18, 1962 and amended by Notarial Deed No. 20 dated September 9, 1963. Based on Notarial Deed No. 18 of Pahala Sutrisno Amijoyo Tampubolon, S.H., M.Kn., dated May 24, 2013, the Company's shareholders approved the change of the Company's status from Foreign Capital Investment (PMA) company to Domestic Capital Investment (PMDN) company.
Read more on LSIP →